Adar Poonawalla, the MD of Serum Institute Of India, is on a takeover spree. It recently took over Magma Fincop (AUM as on June 30 was Rs 14,250 crore) for an undisclosed amount. The company has been renamed Poonawalla Fincorp. It is already infusing capital and repricing loans. It has drawn up plans to grow between 25-30% annually. Recently, it acquired a 50% stake in Schott Kaisa, a JV with the German company from its former owners Kairu Dadachanji and Shapoor Mistry. Schott is into pharma packaging goods including vials which are used in the distribution of vaccines. Insiders believe this is just the beginning and more inorganic growth avenues are being pursued to enable Poonawalla to diversify from vaccine makers to a multifaceted group with interests in finance, manufacturing across sectors and healthcare.